Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series D brings in $16mm for iRhythm Technologies

Executive Summary

Cardiovascular device firm iRhythm Technologies Inc. has raised $16mm through its Series D venture round. Norwest Venture Partners led and was joined by current shareholders New Leaf Ventures, Synergy Life Science Partners, and Kaiser Permanente Ventures. Funds will go towards further commercialization of iRhythm’s Zio patch, a single-use cardiovascular monitor that has been FDA-cleared for use for up to 14 continuous days.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies